In parallel, chronic Chlamydia pneumoniae infection contribute to long-term lung cancer risk, with meta-analyses showing overall OR of 1.5 and subgroup risks up to 2.3 in IgA-positive individuals, likely driven by chronic inflammation [31]. Here, CD79A is linked to lung cancer.